Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, KELLNER TED D, holds the title of Director at AIM ImmunoTech Inc..
On 2026-11-18, the insider transacted 17,526 shares.The shares were transacted at a weighted average price of $0.14 per share, resulting in a total market-relevant value of $2K.
KELLNER TED D (Director) sold $2K of $AIM
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.